Sign up to save your podcasts
Or
Share #004 - Judy Blumstock, CEO at Diamond Therpeutics
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
#004 - Judy Blumstock, CEO at Diamond Therpeutics
Episode 4 - June 3rd 2020
Judy Blumstock - CEO at Diamond Therapeutics
Presented by https://alanaldous.com/ (Alana Armstrong)
DIAMOND THERAPEUTICS
Diamond Therapeutics is developing FDA-approved, psilocybin-based therapeutics that deliver patient benefits without undesired perceptual side effects.
PSYCHEDELIC INSIDERS
Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.
View all episodes
By Microdose Psychedelic InsightsEpisode 4 - June 3rd 2020
Judy Blumstock - CEO at Diamond Therapeutics
Presented by https://alanaldous.com/ (Alana Armstrong)
DIAMOND THERAPEUTICS
Diamond Therapeutics is developing FDA-approved, psilocybin-based therapeutics that deliver patient benefits without undesired perceptual side effects.
PSYCHEDELIC INSIDERS
Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.